Literature DB >> 11742286

Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?

F E Simons1, E S Chan, X Gu, K J Simons.   

Abstract

BACKGROUND: Little information is available about administration of an accurate epinephrine dose to infants experiencing anaphylaxis outside the hospital setting.
OBJECTIVE: Our purpose was to perform a prospective, controlled study of (1) the time needed by parents to draw up an infant epinephrine dose from an ampule and (2) the dose accuracy.
METHODS: We gave 18 parents written instructions and asked them to draw up epinephrine 0.09 mL. We timed them by means of a stopwatch and measured the epinephrine content (in micrograms) in each dose by using HPLC-UV. Eighteen resident physicians, 18 general duty nurses, and 18 emergency department nurses served as controls.
RESULTS: The parents took significantly longer (P < .05) than the controls to draw up the dose; the mean (+/- SEM) times were 142 +/- 13 seconds (range, 83-248) for the parents, 52 +/- 3 seconds (range, 30-83) for the physicians, 40 +/- 2 seconds (range, 26-71) for the general duty nurses, and 29 +/- 0.09 seconds (range, 27-33) for the emergency department nurses. The control groups did not differ significantly from each other in speed (P > .05). The epinephrine content of the doses drawn up by the parents ranged 40-fold in contrast to the physicians' doses (7- to 8-fold), general duty nurses' doses (3-fold), and emergency department nurses' doses (2-fold). The mean epinephrine content did not differ significantly (P > .05) among the 4 groups.
CONCLUSIONS: Most parents were unable to draw up an infant epinephrine dose rapidly or accurately. Most health care professionals drew up the dose rapidly; however, their accuracy was compromised by inherent variations of epinephrine concentrations in the ampules (United States Pharmacopeia compendial limits, 90% to 115%) and the inherent difficulty of measuring low volumes (<0.1 mL) of epinephrine. User-friendly premeasured epinephrine doses suitable for infants should be developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742286     DOI: 10.1067/mai.2001.119916

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

Review 1.  Food allergy in children.

Authors:  V R Baral; J O'B Hourihane
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

Review 2.  Recognition and management of food-induced anaphylaxis.

Authors:  Corinne Keet
Journal:  Pediatr Clin North Am       Date:  2011-03-05       Impact factor: 3.278

Review 3.  Anaphylaxis in children.

Authors:  Karen S Farbman; Kenneth A Michelson
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

Review 4.  Clinical Immunology Review Series: An approach to the patient with allergy in childhood.

Authors:  R Sporik; J Henderson; J O'B Hourihane
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 5.  Evidence update for the treatment of anaphylaxis.

Authors:  Amy Dodd; Anna Hughes; Nicholas Sargant; Andrew F Whyte; Jasmeet Soar; Paul J Turner
Journal:  Resuscitation       Date:  2021-04-23       Impact factor: 5.262

Review 6.  Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

Review 7.  CSACI position statement: epinephrine auto-injectors and children < 15 kg.

Authors:  Michelle Halbrich; Douglas P Mack; Stuart Carr; Wade Watson; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2015-06-12       Impact factor: 3.406

Review 8.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

9.  Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.

Authors:  Stephen F Kemp; Richard F Lockey; F Estelle R Simons
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

Review 10.  The role of epinephrine in the treatment of anaphylaxis.

Authors:  Anne K Ellis; James H Day
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.